Stay updated on Tezepelumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Tezepelumab in Chronic Urticaria Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a site maintenance/versioning update with no changes to the study data or page content.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 has been added and the notices for v3.4.1 and the lapse in government funding have been removed; these are minor site maintenance updates and do not alter study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center operations with links to cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check68 days agoChange DetectedThe page adds a glossary toggle (Show glossary / Hide glossary) and includes minor textual updates for QC criteria labeling and FEAR Act Data capitalization. It also shows the new footer revision note 'Revision: v3.4.0' (replacing v3.3.4).SummaryDifference0.2%

- Check83 days agoChange DetectedUpdated the site revision from v3.3.3 to v3.3.4. No user-facing content or core functionality appears to be affected.SummaryDifference0.0%

Stay in the know with updates to Tezepelumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.